Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness

NCT03652181 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT03652181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03652181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness
Lead sponsor
University of Chicago
Phase
Observational
Overall status
Completed
Start date
August 20, 2018
Completion date
November 3, 2022
Enrollment
123 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cavernoma, cavernous angioma, ccm, cerebral cavernous malformation, cerebral cavernous malformations 1, cerebral cavernous malformations 2, cerebral cavernous malformations 3